ESC Congress 2017 In Review Official peer-reviewed highlights Focus on Arrhythmias In This Issue Evolving Treatments for Atrial Fibrillation An examination of the current use of antiarrhythmic drugs for atrial fibrillation and what the future may hold, as well as a look at new tools and hybrid approaches for ablation, and whether or not real world data supports our expectations for NOACs. Also Anticoagulation for Cardioversion of AF Clinical Trial Highlights A product of This publication is supported by Boehringer Ingelheim Dhr. Dr. G.J. Heijnsbroek Am Römerguell 34 D-54634 Bitburg GERMANY ICDs: Four Decades of Evidence